Evidence map›Paper›PMID 29874543›Full record

ArticleThe New England journal of medicine2018

The Microbiome and Systemic Lupus Erythematosus.

James T Rosenbaum, Gregg J Silverman

Abstract readComment
PubMed Publisher
In one paragraph

Article in The New England journal of medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. The microbiome in SLE pathogenesis.Nature reviews. Rheumatology · 2019
    Article
  15. Article
  16. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

James T RosenbaumFrom Oregon Health and Science University and the Legacy Devers Eye Institute, Portland (J.T.R.); and New York University Medical Center, New York (G.J.S.).
Gregg J SilvermanFrom Oregon Health and Science University and the Legacy Devers Eye Institute, Portland (J.T.R.); and New York University Medical Center, New York (G.J.S.).

Funding

Translational Center of Molecular Profiling in Preclinical and Established Lupus (COMPEL)P50AR070591 · NIAMS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI BUYON, JILL P · 2017 to 2021
$6.7M
Gut dysbiosis and tryptophan metabolism in lupusR01AI143313 · NIAID · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI Laurence Morel, Gregg Joshua Silverman · 2019 to 2026
$3.3M
Thromboinflammatory pathways triggered by gut dysbiosis in patients with LupusR21AI180737 · NIAID · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI SILVERMAN, GREGG JOSHUA · 2024 to 2025
$460k
NIAID NIH HHS R01 AI143313NIAID NIH HHS R21 AI180737
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Lupus Erythematosus, SystemicMicrobiotaHumans

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.